RIPK2 was found to be significantly upregulated in rectal tumor tissues compared with normal adjacent mucosa, suggesting that RIPK2 plays a vital role in the progression of IBD to CRC (Flebbe et al., 2019). The gene discussed is RIPK2; the disease is colorectal carcinoma.